Business
New Product Development and Board Change
New Product Development and Board Change.
About this update from Venture Life Group Plc
[{"type":"text","content":"\n \nRNS Number : 3537O Venture Life Group PLC 06 August 2014 \n\n \n \nVenture Life Group plc\n(\"Venture Life\" or \"the Group\")\nNew Product Development and Board Change\n \nBracknell, UK - [6] August 2014: Venture Life Group plc (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that, as part of its longer term strategy, it will be managing its new product development activities from its recently acquired Italian subsidiary, Biokosmes, under the direct responsibility of Gianluca Braguti, the Group's Manufacturing Director. Consequently, Dr John Lucas has stepped down as Director of New Product Development and left the Group on 5 August 2014 by mutual agreement.\nCommenting on the announcement, Jerry Randall, Chief Executive Officer of Venture Life, said: \"On behalf of the Board I would like to thank John for his contribution to the Group and we wish him well for the future.\n\"Concentrating our new product development activities at Biokosmes, which has been successfully developing innovative healthcare products for over 25 years, better aligns our expertise and resources with our longer term product development strategy.\"\n- Ends -\n \nFor further information please contact:\nVenture Life Group PLC\nJerry Randall, Chief Executive Officer\nJames Hunter, Chief Financial Officer +44 (0) 1344 742870\n \nWG Partners (Broker) \nJonathan Gosling\nClaes Spång +44 (0) 20 3693 1566 \n \nCharles Stanley Securities (Nominated Adviser) \nPhil Davies ...